نتائج البحث - "Gilloteau, I."

1

دورية أكاديمية

Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from the CLEAR study

المؤلفون: Blauvelt, A, Reich, K, Mehlis, S, Vanaclocha, F, Sofen, H, Abramovits, W, Zhao, Y, Gilloteau, I, Davenport, E, Williams, N, Guana, A, Tyring, S

المصدر: Journal of the European Academy of Dermatology and Venereology. 31(10)

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/9vz503s2Test

View record in eScholarship

2

دورية أكاديمية

Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long‐term Results of Two Phase III Randomized Controlled Trials

المؤلفون: Kvien, TK, Conaghan, PG, Gossec, L, Strand, V, Østergaard, M, Poddubnyy, D, Williams, N, Porter, B, Shete, A, Gilloteau, I, Deodhar, A

وصف الملف: text

العلاقة: https://eprints.whiterose.ac.uk/169476/7/Arthritis%20Care%20%20%20Research%20-%202020%20-%20Kvien%20-%20Secukinumab%20and%20Sustained%20Reduction%20in%20Fatigue%20in%20Patients%20With%20Ankylosing.pdfTest; Kvien, TK, Conaghan, PG orcid.org/0000-0002-3478-5665 , Gossec, L et al. (8 more authors) (2022) Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long‐term Results of Two Phase III Randomized Controlled Trials. Arthritis Care & Research, 74 (5). pp. 759-767. ISSN 2151-464X

الإتاحة: https://eprints.whiterose.ac.uk/169476Test/
https://eprints.whiterose.ac.uk/169476/7/Arthritis%20Care%20%20%20Research%20-%202020%20-%20Kvien%20-%20Secukinumab%20and%20Sustained%20Reduction%20in%20Fatigue%20in%20Patients%20With%20Ankylosing.pdfTest

View record in BASE

3

دورية أكاديمية

The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial

المؤلفون: Strand, V, Kaeley, GS, Bergman, MJ, Gladman, DD, Coates, LC, Sherif, B, Hur, P, Parikh, B, Gilloteau, I, Mease, PJ

العلاقة: https://ora.ox.ac.uk/objects/uuid:c1d5fcbb-46cd-4d37-bd00-8a22c4d9669dTest; https://doi.org/10.1016/S2665-9913Test(21)00354-4

الإتاحة: https://doi.org/10.1016/S2665-9913Test(21)00354-4
https://ora.ox.ac.uk/objects/uuid:c1d5fcbb-46cd-4d37-bd00-8a22c4d9669dTest

View record in BASE

4

مؤتمر

Secukinumab relieves anxiety/depression up to 1 year in patients treated for psoriatic arthritis and moderate to severe psoriasis: an overview from phase 3 clinical trials

المؤلفون: Behrens, F, Mease, P, Lebwohl, M, Thaci, D, Gilloteau, I, Fox, T, DiComite, G, Guana, A, Jugl, S, Peterlik, D, Lefèvre, S, Gottlieb, AB

المصدر: 46. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 32. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), Wissenschaftliche Herbsttagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR); 20180919-20180922; Mannheim; DOCSpA.21 /20190205/

مصطلحات موضوعية: ddc: 610

العلاقة: http://dx.doi.org/10.3205/18dgrh163Test; http://nbn-resolving.de/urn:nbn:de:0183-18dgrh1631Test; http://www.egms.de/en/meetings/dgrh2018/18dgrh163.shtmlTest

الإتاحة: https://doi.org/10.3205/18dgrh163Test
http://nbn-resolving.de/urn:nbn:de:0183-18dgrh1631Test
http://www.egms.de/en/meetings/dgrh2018/18dgrh163.shtmlTest

View record in BASE

5

The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial

المؤلفون: Strand, V, Kaeley, GS, Bergman, MJ, Gladman, DD, Coates, LC, Sherif, B, Hur, P, Parikh, B, Gilloteau, I, Mease, PJ

المصدر: The Lancet Rheumatology. 4:e208-e219

مصطلحات موضوعية: Rheumatology, Immunology, Immunology and Allergy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19b175581bf1a0955a0b0dc40fac78b1Test
https://doi.org/10.1016/s2665-9913Test(21)00354-4

6

دورية أكاديمية

Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment : Results from the CLEAR study

المؤلفون: Thaçi, Diamant, Puig Sanz, Lluís., Reich, K., Tsai, T. F., Tyring, S., Kingo, K., Ziv, M., Pinter, A., Vender, Ronald, Lacombe, A., Xia, Shang, Bhosekar, V., Gilloteau, I., Guana, A., Blauvelt, Andrew, Universitat Autònoma de Barcelona

وصف الملف: application/pdf

العلاقة: Journal of the American Academy of Dermatology; Vol. 81 Núm. 6 (december 2019), p. 1405-1409; https://ddd.uab.cat/record/222744Test; urn:10.1016/j.jaad.2019.04.045; urn:oai:ddd.uab.cat:222744; urn:scopus_id:85074743708; urn:articleid:10976787v81n6p1405; urn:pmid:31399223; urn:oai:egreta.uab.cat:publications/d2c535cc-6e38-442e-82a0-f623360c21b9

الإتاحة: https://ddd.uab.cat/record/222744Test

View record in BASE

7

دورية أكاديمية

PBI24 SECUKINUMAB VS ADALIMUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: A COST PER RESPONDER ANALYSIS AT 52 WEEKS FROM AN ALGERIAN PERSPECTIVE

المؤلفون: Mestouri, A., Kooli, A., Bouchaour, N., Gilloteau, I.

المصدر: Value in Health ; volume 22, page S421 ; ISSN 1098-3015

مصطلحات موضوعية: Public Health, Environmental and Occupational Health, Health Policy

الإتاحة: https://doi.org/10.1016/j.jval.2019.09.128Test
https://api.elsevier.com/content/article/PII:S1098301519325069?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1098301519325069?httpAccept=text/plainTest

View record in BASE

8

دورية أكاديمية

PSY19 A COST PER RESPONDER ANALYSIS OF SECUKINUMAB COMPARED TO OTHER BIOLOGICS FOR TREATMENT OF MODERATE TO SEVERE PSORIASIS PATIENTS OVER 1 YEAR IN MOROCCO

المؤلفون: Yahiaoui, S., Panguluri, S., MZah, D., Marrakchi, T., Ammar, A., Gunda, P., Kooli, A., Gilloteau, I.

المصدر: Value in Health ; volume 22, page S904-S905 ; ISSN 1098-3015

مصطلحات موضوعية: Public Health, Environmental and Occupational Health, Health Policy

الإتاحة: https://doi.org/10.1016/j.jval.2019.09.2647Test
https://api.elsevier.com/content/article/PII:S1098301519350259?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1098301519350259?httpAccept=text/plainTest

View record in BASE

9

دورية أكاديمية

Secukinumab significantly reduces psoriasis-related work impairment and indirect costs compared with ustekinumab and etanercept in the United Kingdom

المؤلفون: Warren, R B, Halliday, A, Graham, C N, Gilloteau, I, Miles, L, McBride, D

المصدر: Warren , R B , Halliday , A , Graham , C N , Gilloteau , I , Miles , L & McBride , D 2018 , ' Secukinumab significantly reduces psoriasis-related work impairment and indirect costs compared with ustekinumab and etanercept in the United Kingdom ' , Journal of the European Academy of Dermatology and Venereology : JEADV . https://doi.org/10.1111/jdv.15094Test

الإتاحة: https://doi.org/10.1111/jdv.15094Test
https://research.manchester.ac.uk/en/publications/a9d63da8-4d7f-469d-a915-8fe5eafc2ff7Test

View record in BASE

10

دورية أكاديمية

A multidimensional assessment of the burden of psoriasis:Results from a multinational dermatologist and patient survey

المؤلفون: Griffiths, C E M, Jo, S J, Naldi, L, Romiti, R, Guevara-Sangines, E, Howe, T, Pietri, G, Gilloteau, I, Richardson, C, Tian, H, Augustin, M

المصدر: Griffiths , C E M , Jo , S J , Naldi , L , Romiti , R , Guevara-Sangines , E , Howe , T , Pietri , G , Gilloteau , I , Richardson , C , Tian , H & Augustin , M 2018 , ' A multidimensional assessment of the burden of psoriasis : Results from a multinational dermatologist and patient survey ' , The British journal of dermatology , vol. 179 , no. 1 , pp. 173-181 . https://doi.org/10.1111/bjd.16332Test

مصطلحات موضوعية: Journal Article

الإتاحة: https://doi.org/10.1111/bjd.16332Test
https://research.manchester.ac.uk/en/publications/e65441ae-deb8-484d-8e99-8181ea8f56c0Test
http://www.scopus.com/inward/record.url?scp=85042224971&partnerID=8YFLogxKTest
http://www.mendeley.com/research/multidimensional-assessment-burden-psoriasis-results-multinational-dermatologist-patient-surveyTest

View record in BASE

تنقيح النتائج